Ventris Medical

medical devices

About

It's the Ventris focus on quality, donor selection, tissue recover, and processing protocols that sets us apart. The company is dedicated to providing products that adhere to the strictest current tissue banking and processing standards, with the ultimate goal of an exceptional outcome for the patient. Our line of human allograft products is regulated by the FDA Center for Biologics Evaluation and Research (CBER), which regulates human cells, tissues, and cellular and tissue-based products (HCT/Ps). Ventris adheres to Current Good Tissue Practices, focusing extensively on donor eligibility and the recovery process. Ventris Allograft products are regulated under 21 CFR Part 1270 and 21 CFR Part 1271 and Section 361 of the Public Health Services Act.

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Google Tag Manager Mobile Friendly Linkedin Widget Google Analytics WordPress.org Nginx Linkedin Login Remote IoT

Keywords

medical equipment manufacturing bone grafts medical devices biologics supply chain medical equipment and supplies manufacturing synthetic bone graft biologics tissue recovery osteobiologics inductive fibers tissue sterilization tissue processing biologics manufacturing tissue engineering biological barrier surgical grafts tissue donation fda regulated regulatory compliance minimally manipulated tissue tissue tracking biologic solutions biologics for wound management healthcare patient care tissue preservation cellular grafts amniotic tissue biologics for orthopedic surgery proprietary clearant technology

Location

1201 Dove St, Newport Beach, California, United States, 92660-2813

Related Companies

Companies in the same industry